Haleon logo

Haleon

Stock
Stock
ISIN: GB00BMX86B70
Ticker: HLN
GB00BMX86B70
HLN

Price

Price

CHART BY

Historical dividends and forecast

All dividend data

Haleon has so far distributed $0.0656 in 2026. The next dividend will be paid on 17.09.2026


$0.0841

CHART BY

Frequently asked questions

The market capitalization of Haleon is $39.98B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
The Price-to-Earnings (P/E) ratio (TTM) for Haleon is 18.46. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
Haleon's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $0.246. EPS indicates the company's profitability on a per-share basis.
Currently, 18 analysts cover Haleon's stock, with a consensus target price of $5.723. Analyst ratings provide insights into the stock's expected performance.
Over the trailing twelve months, Haleon reported a revenue of $15.08B.
Yes, Haleon is paying dividends. The next payment is scheduled for 17.09.2026, with an expected amount of .
Haleon's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $3.99B. EBITDA measures the company's overall financial performance.
Haleon has a free cash flow of $2.74B. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
The free float of Haleon is 8.40B. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$39.98B
EPS (TTM) 
$0.246
Free Float 
8.40B
P/E ratio (TTM) 
18.46
Revenue (TTM) 
$15.08B
EBITDA (TTM) 
$3.99B
Free Cashflow (TTM) 
$2.74B

Pricing

1D span
$4.56$4.624
52W span
$4.266$5.616

Analyst Ratings

The price target is $5.723 and the stock is covered by 18 analysts.

Buy

11

Hold

5

Sell

2

Information

Haleon Plc engages in the provision of personal healthcare products. The firm focuses on consumer healthcare. It operates under the following geographical segments: North America, EMEA and LatAm, and Asia Pacific. The company was founded on July 18, 2022 and is headquartered in Weybridge, the United Kingdom.

Industries
Major Pharmaceuticals
Sector
Health Care

Identifier

ISIN
GB00BMX86B70
Primary Ticker
HLN

Knockouts

Real-time data from LSX · Fundamentals & EOD data from FactSet
Join the conversation